Ausgabe Sonderheft 2/2002
Inhalt (8 Artikel)
Clinical effects of alemtuzumab (Campath-1H) in B-cell chronic lymphocytic leukemia
Anders Osterborg, Hakan Mellstedt, Michael Keating
Alemtuzumab in T-cell malignancies
Claire E. Dearden, Estella Matutes, Daniel Catovsky
Immunological effects and safe administration of alemtuzumab (MabCampath™) in advanced B-CLL
Ben Kennedy, Peter Hillmen